Management of hereditary angioedema with C1-deficiency - consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations

被引:5
作者
Porebski, Grzegorz [1 ]
Gocki, Jacek [2 ]
Juchacz, Aldona [3 ]
Kucharczyk, Aleksandra [4 ]
Matuszewski, Tomasz [5 ]
Olejniczak, Katarzyna [6 ]
Sokolowska, Malgorzata [7 ]
Stobiecki, Marcin [1 ]
Trebas-Pietras, Ewa [8 ]
Obtulowicz, Krystyna [1 ]
机构
[1] Uniwersytet Jagiellonski, Coll Med Krakowie, Zaklad Alergolog Klinicznej & Srodowiskowej, Krakow, Poland
[2] Uniwersytet Mikolaja Kopernika Toruniu, Coll Med Bydgoszczy, Katedra & Klin Alergol Immunol Kliniczne & Chorob, Torun, Poland
[3] Wielkopolskie Ctr Pulmonol & Torkochirurg Poznan, Poznan, Poland
[4] Wojskowy Inst Med Warszawie, Klin Chorob Wewnetrznych Pneumonol Alergol & Immu, Warsaw, Poland
[5] Wojskowy Inst Medyczny Warszawie, Klin Chorob Infekcyjnych & Alergol, Warsaw, Poland
[6] Uniwersytet Med Poznaniu, Klin Pneumonol Alergol Dzieciecej & Immunol Klini, Poznan, Poland
[7] Pomorski Uniwersytet Med Szczecinie, Samodzielny Publiczny Szpital Kliniczny 2, Poradnia Alergologiczna, Szczecin, Poland
[8] Wojewodzki Szpital Specjalistyczny Stefana Kardyn, Oddzial Alergol & Chorob Pluc, Lublin, Poland
关键词
hereditary angioedema; C1-inhibitor; management; treatment; recommendations;
D O I
10.5114/pja.2018.76680
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The second part of the consensus statement aimed at management of hereditary angioedema (HAE). The currently available therapeutic options for acute and long-term treatment in HAE are presented in the light of the recently published evidence based research and recommendations. The specific situations are also addressed, namely, home treatment, management of patient with some coexisting medical conditions and management of selected subpopulations, including pregnant women and children. The significance of the close collaboration with patients is emphasized. The outcome of the statement is to improve management and uniform care of HAE patients in Poland.
引用
收藏
页码:109 / 120
页数:12
相关论文
共 77 条
  • [51] Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate
    Martinez-Saguer, Inmaculada
    Rusicke, Eva
    Aygoren-Pursun, Emel
    Heller, Christine
    Klingebiel, Thomas
    Kreuz, Wolfhart
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (02) : 131.e1 - 131.e7
  • [53] The international WAO/EAACI guideline for the management of hereditary angioedemaThe 2017 revision and update
    Maurer, M.
    Magerl, M.
    Ansotegui, I.
    Aygoeren-Puersuen, E.
    Betschel, S.
    Bork, K.
    Bowen, T.
    Boysen, H. Balle
    Farkas, H.
    Grumach, A. S.
    Hide, M.
    Katelaris, C.
    Lockey, R.
    Longhurst, H.
    Lumry, W. R.
    Martinez-Saguer, I.
    Moldovan, D.
    Nast, A.
    Pawankar, R.
    Potter, P.
    Riedl, M.
    Ritchie, B.
    Rosenwasser, L.
    Sanchez-Borges, M.
    Zhi, Y.
    Zuraw, B.
    Craig, T.
    [J]. ALLERGY, 2018, 73 (08) : 1575 - 1596
  • [54] Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment
    Maurer, Marcus
    Aberer, Werner
    Bouillet, Laurence
    Caballero, Teresa
    Fabien, Vincent
    Kanny, Gisele
    Kaplan, Allen
    Longhurst, Hilary
    Zanichelli, Andrea
    [J]. PLOS ONE, 2013, 8 (02):
  • [55] Obtulowicz K., 2016, ALERGOL IMMUNOL, V13, P19
  • [56] Obtulowicz K, 2008, ALERG ASTMA IMMUNOL, V13, P91
  • [57] Treatment of hereditary angioneurotic oedema (HANE) with tibolone
    Ott, H. W.
    Mattle, V.
    Hadziomerovic, D.
    Licht, P.
    Doeinghaus, K.
    Rubbert, A.
    Manger, K.
    Manger, B.
    Kalden, J.
    Wildt, L.
    [J]. CLINICAL ENDOCRINOLOGY, 2007, 66 (02) : 180 - 184
  • [58] Complement Study Versus CINH Gene Testing for the Diagnosis of Type I Hereditary Angioedema in Children
    Pedrosa, Maria
    Phillips-Angles, Elsa
    Lopez-Lera, Alberto
    Lopez-Trascasa, Margarita
    Caballero, Teresa
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (01) : 16 - 18
  • [59] The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach?
    Porebski, G.
    [J]. ALLERGY, 2013, 68 (09) : 1207 - 1207
  • [60] Porebski G, 2015, ALERGOL IMMUNOL, V12, P21